Should I buy or sell Motus GI stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MOTS shares. View MOTS analyst ratings or view top-rated stocks .

What is Motus GI's stock price target for 2024?

2 brokers have issued 1 year target prices for Motus GI's shares. Their MOTS share price targets range from $20.25 to $37.50. On average, they anticipate the company's stock price to reach $28.88 in the next twelve months. This suggests a possible upside of 2,164.7% from the stock's current price. View analysts price targets for MOTS or view top-rated stocks among Wall Street analysts .

How have MOTS shares performed in 2023?

Motus GI's stock was trading at $12.60 on January 1st, 2023. Since then, MOTS shares have decreased by 89.9% and is now trading at $1.2750. View the best growth stocks for 2023 here .

When is Motus GI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our MOTS earnings forecast .

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) posted its quarterly earnings results on Monday, November, 13th. The company reported ($4.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.20) by $2.92. The company earned $0.09 million during the quarter, compared to analysts' expectations of $0.13 million. Motus GI had a negative trailing twelve-month return on equity of 3,413.36% and a negative net margin of 3,776.10%.

When did Motus GI's stock split?

Motus GI's stock reverse split before market open on Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Motus GI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Matinas BioPharma (MTNB) , Allena Pharmaceuticals (ALNA) , VYNE Therapeutics (VYNE) , Rigel Pharmaceuticals (RIGL) , TherapeuticsMD (TXMD) , Sorrento Therapeutics (SRNE) , Pfizer (PFE) , Gilead Sciences (GILD) and Marinus Pharmaceuticals (MRNS) .

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

How do I buy shares of Motus GI?

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

$1.27

-0.14 (-9.89%)

(As of 12/29/2023 ET)

Compare

Today's Range: $1.21
▼
$1.48
50-Day Range: $1.25
▼
$10.04
52-Week Range: $1.14
▼
$23.40

Volume: 272,895 shs
Average Volume: 160,638 shs
Market Capitalization: $739,500.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $28.88

Motus GI MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 2,164.7% Upside
$28.88 Price Target
Short Interest: Bearish
11.25% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($28.03) to ($11.73) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Motus GI has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $28.88, Motus GI has a forecasted upside of 2,164.7% from its current price of $1.28.
Amount of Analyst Coverage
Motus GI has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
11.25% of the float of Motus GI has been sold short.
Short Interest Ratio / Days to Cover
Motus GI has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Motus GI has recently increased by 4.94%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Motus GI does not currently pay a dividend.
Dividend Growth
Motus GI does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MOTS.

2.7

News and Social Media Coverage

News Sentiment
Motus GI has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Motus GI this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for MOTS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Motus GI insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.63% of the stock of Motus GI is held by insiders.
Percentage Held by Institutions
Only 8.61% of the stock of Motus GI is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Motus GI are expected to grow in the coming year, from ($28.03) to ($11.73) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Motus GI is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Motus GI is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Motus GI has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Motus GI Stock (NASDAQ:MOTS)

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.

MOTS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MOTS Stock News Headlines

December 21, 2023 | finance.yahoo.com

Investors in Motus Holdings (JSE:MTH) have seen splendid returns of 101% over the past three years

December 19, 2023 | msn.com

Why Motus GI Holdings (MOTS) Shares Are Down 46%

December 31, 2023 | Behind the Markets (Ad)

New Year's Sale: Get 12 Months of Stock Picks for $9.00

Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this.

December 19, 2023 | msn.com

Enphase Energy Layoffs 2023: What to Know About the Latest ENPH Job Cuts

December 19, 2023 | msn.com

Why Is Motus GI (MOTS) Stock Down 44% Today?

December 19, 2023 | msn.com

Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket

December 18, 2023 | finance.yahoo.com

Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering

December 5, 2023 | finance.yahoo.com

Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?

December 31, 2023 | Behind the Markets (Ad)

New Year's Sale: Get 12 Months of Stock Picks for $9.00

November 19, 2023 | finance.yahoo.com

At R102, Is Motus Holdings Limited (JSE:MTH) Worth Looking At Closely?

November 14, 2023 | finanznachrichten.de

Motus GI Holdings, Inc.: Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 13, 2023 | finance.yahoo.com

Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 10, 2023 | msn.com

What's Going On With Medical Technology Company Motus GI's Shares Today?

November 10, 2023 | finance.yahoo.com

Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro

November 2, 2023 | finance.yahoo.com

We Take A Look At Why Motus Holdings Limited's (JSE:MTH) CEO Has Earned Their Pay Packet

November 1, 2023 | finance.yahoo.com

Motus GI Announces 1-for-15 Reverse Stock Split

October 23, 2023 | finance.yahoo.com

With 52% ownership of the shares, Motus Holdings Limited (JSE:MTH) is heavily dominated by institutional owners

September 26, 2023 | finance.yahoo.com

Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon

September 14, 2023 | finance.yahoo.com

Motus GI Amends Royalty Agreement

September 6, 2023 | finance.yahoo.com

Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

September 1, 2023 | finance.yahoo.com

Motus Holdings Full Year 2023 Earnings: In Line With Expectations

August 24, 2023 | finance.yahoo.com

Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 16, 2023 | markets.businessinsider.com

Motus Gi Holdings (MOTS) Gets a Buy from H.C. Wainwright

August 15, 2023 | finanznachrichten.de

Motus GI Holdings, Inc.: Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 15, 2023 | fr.investing.com

Le BPA de Motus GI Holdings a dépassé les attentes de 0,21$, le CA en dessous des prévisions

August 14, 2023 | finance.yahoo.com

Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

July 27, 2023 | finance.yahoo.com

Motus Holdings (JSE:MTH) Is Reinvesting At Lower Rates Of Return

See More Headlines

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/13/2023
Today: 12/31/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/29/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MOTS
CUSIP: N/A
CIK: 1686850
Web: www.motusgi.com
Phone: (954) 541-8000
Fax: 954-541-8265
Employees: 43
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $28.88
High Stock Price Target: $37.50
Low Stock Price Target: $20.25
Potential Upside/Downside: +2,164.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($35.9140)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,600,000.00
Net Margins: -3,776.10%
Pretax Margin: -3,775.82%
Return on Equity: -3,413.36%
Return on Assets: -96.95%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.49
Quick Ratio: 1.40

Sales & Book Value

Annual Sales: $590,000.00
Price / Sales: 1.25
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $9.58 per share
Price / Book: 0.13

Miscellaneous

Outstanding Shares: 580,000
Free Float: 552,000
Market Cap: $739,500.00
Optionable: Not Optionable
Beta: 1.54

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Mark Pomeranz (Age 61)
Non-Independent Director & CEO
Comp: $429.31k
Ms. Ravit Ram
CFO & VP of Global Operations
Mr. Elad Amor
Chief Accounting Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

MOTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Motus GI stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MOTS shares.
View MOTS analyst ratings or view top-rated stocks.
What is Motus GI's stock price target for 2024?: 2 brokers have issued 1 year target prices for Motus GI's shares. Their MOTS share price targets range from $20.25 to $37.50. On average, they anticipate the company's stock price to reach $28.88 in the next twelve months. This suggests a possible upside of 2,164.7% from the stock's current price.
View analysts price targets for MOTS or view top-rated stocks among Wall Street analysts.
How have MOTS shares performed in 2023?: Motus GI's stock was trading at $12.60 on January 1st, 2023. Since then, MOTS shares have decreased by 89.9% and is now trading at $1.2750.
View the best growth stocks for 2023 here.
When is Motus GI's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our MOTS earnings forecast.
How were Motus GI's earnings last quarter?: Motus GI Holdings, Inc. (NASDAQ:MOTS) posted its quarterly earnings results on Monday, November, 13th. The company reported ($4.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.20) by $2.92. The company earned $0.09 million during the quarter, compared to analysts' expectations of $0.13 million. Motus GI had a negative trailing twelve-month return on equity of 3,413.36% and a negative net margin of 3,776.10%.

When did Motus GI's stock split?: Motus GI's stock reverse split before market open on Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What other stocks do shareholders of Motus GI own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), VYNE Therapeutics (VYNE), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE), Pfizer (PFE), Gilead Sciences (GILD) and Marinus Pharmaceuticals (MRNS).
When did Motus GI IPO?: (MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.
How do I buy shares of Motus GI?: Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MOTS) was last updated on 12/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Motus GI Stock (NASDAQ:MOTS)

MOTS Stock Price History

MOTS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

MOTS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™